We are live on ! Find out more
EAM

Eagle Asset Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 41.58%
This Fund
S&P 500
This Quarter Est. Return
+7.97%
1 Year Est. Return
+41.58%
3 Year Est. Return
+53.38%
5 Year Est. Return
+214.12%
10 Year Est. Return
+691.23%
AUM
$15B
AUM Growth
+$337M
Cap. Flow
-$447M
Cap. Flow %
-2.99%
Top 10 Hldgs %
10.92%
Holding
694
New
52
Increased
258
Reduced
282
Closed
67

Top Buys

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$55.1M
2
CUBE icon
CubeSmart
CUBE
+$49.2M
3
STE icon
Steris
STE
+$43.7M
4
EQY
Equity One
EQY
+$39M
5
EXPE icon
Expedia Group
EXPE
+$36.5M

Sector Composition

Rank Sector Weight
1 Technology 18.69%
2 Healthcare 17.39%
3 Industrials 14.8%
4 Consumer Discretionary 12.55%
5 Financials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STJ
26
DELISTED
St Jude Medical
STJ
$92.6M 0.62%
1,499,112
-86,106
-5% -$5.43M
COHR
27
DELISTED
Coherent Inc
COHR
$90.6M 0.61%
1,391,567
+29,553
+2% +$1.82M
AMAT icon
28
Applied Materials
AMAT
$426B
$90.4M 0.6%
4,842,276
-370,448
-7% -$6.43M
BC icon
29
Brunswick
BC
$5.19B
$88M 0.59%
1,743,044
+76,553
+5% +$3.95M
WWAV
30
DELISTED
The WhiteWave Foods Company
WWAV
$87.1M 0.58%
2,239,647
+72,035
+3% +$2.91M
SF
31
Stifel
SF
$12.3B
$86.9M 0.58%
4,618,201
-123,501
-3% -$2.4M
FTNT icon
32
Fortinet
FTNT
$112B
$84.9M 0.57%
13,611,710
-1,373,325
-9% -$9.86M
IMPV
33
DELISTED
Imperva, Inc.
IMPV
$83.2M 0.56%
1,314,414
-21,357
-2% -$1.45M
ISEE
34
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$83M 0.55%
1,056,719
-4,203
-0.4% -$243K
PFPT
35
DELISTED
Proofpoint, Inc.
PFPT
$80.7M 0.54%
1,241,822
-9,796
-0.8% -$656K
VSI
36
DELISTED
Vitamin Shoppe Inc.
VSI
$79M 0.53%
2,415,062
-512,865
-18% -$16.3M
DD
37
DELISTED
Du Pont De Nemours E I
DD
$78.8M 0.53%
1,182,697
-66,288
-5% -$4.21M
ABT icon
38
Abbott
ABT
$180B
$78.7M 0.53%
1,753,120
+17,650
+1% +$779K
RSPP
39
DELISTED
RSP Permian, Inc.
RSPP
$78.3M 0.52%
3,209,971
+182,288
+6% +$4.85M
BURL icon
40
Burlington
BURL
$22B
$77.2M 0.52%
1,798,621
+213,783
+13% +$9.9M
PBH icon
41
Prestige Consumer Healthcare
PBH
$2.35B
$76.9M 0.51%
1,493,653
-26,899
-2% -$1.34M
MMM icon
42
3M
MMM
$89B
$76.7M 0.51%
609,214
+4,442
+0.7% +$571K
ACOR
43
DELISTED
Acorda Therapeutics
ACOR
$76.5M 0.51%
14,905
-1,320
-8% -$5.77M
UNP icon
44
Union Pacific
UNP
$183B
$75.9M 0.51%
970,222
-84,732
-8% -$7.27M
APTV icon
45
Aptiv
APTV
$12B
$75.9M 0.51%
884,983
-96,836
-10% -$8.1M
MRK icon
46
Merck
MRK
$324B
$75.7M 0.51%
1,502,257
+6,279
+0.4% +$317K
PTC icon
47
PTC
PTC
$13.7B
$75.4M 0.5%
2,178,495
-165,011
-7% -$5.78M
STE icon
48
Steris
STE
$20.9B
$75.3M 0.5%
999,797
+604,654
+153% +$43.7M
WST icon
49
West Pharmaceutical
WST
$23.1B
$74.3M 0.5%
1,233,635
+321,188
+35% +$19.3M
PEP icon
50
PepsiCo
PEP
$186B
$74.3M 0.5%
743,482
+11,579
+2% +$1.16M

Similar funds

Eagle Asset Management's Q4 2015 Portfolio in Review

As of Q4 2015, Eagle Asset Management held 694 positions worth $15B, up 2.3% from $14.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Eagle Asset Management's Q4 2015 filing shows 52 new, 258 increased, 282 reduced and 67 closed positions. Its largest new stake was Abiomed Inc: 648,785 shares worth $58.6M. The largest sale was THORATEC CORPORATION, an estimated $132M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Eagle Asset Management's largest Q4 2015 buy was Abiomed Inc: 648,785 shares worth $58.6M.
  • Eagle Asset Management added most to Steris in Q4 2015, an estimated $43.7M increase.
  • Eagle Asset Management's biggest Q4 2015 reduction was SIRONA DENTAL SYSTEMS INC COM STK, cutting an estimated $59.3M.
  • Eagle Asset Management fully exited THORATEC CORPORATION in Q4 2015, selling an estimated $132M.
  • Eagle Asset Management's ten largest holdings make up 11% of its $15B portfolio in Q4 2015.
  • Eagle Asset Management opened 52 new positions and closed 67 in Q4 2015.
  • Eagle Asset Management's portfolio value rose 2.3% quarter-over-quarter to $15B.

Based on Eagle Asset Management's 13F filing for Q4 2015, filed 3 Feb 2016.